|
|
Debra F. Higgins, Kuniko Kimura, Wanja M. Bernhardt, Nikita Shrimanker, Yasuhiro Akai, Bernd Hohenstein, Yoshihiko Saito, Randall S. Johnson, Matthias Kretzler, Clemens D. Cohen, Kai-Uwe Eckardt, Masayuki Iwano, Volker H. Haase
J Clin Invest. 2007;
117(12):3810
doi:10.1172/JCI30487
Abstract |
Full text
| PDF
| Supplemental material

H
ypoxia has been proposed as an important microenvironmental factor in the development of tissue fibrosis; however, the underlying mechanisms are not well defined. To examine the role of hypoxia-inducible factor–1 (HIF-1), a key mediator of cellular adaptation to hypoxia, in the development of fibrosis in mice, we inactivated Hif-1α in primary renal epithelial cells and in proximal tubules of kidneys subjected to unilateral ureteral obstruction (UUO) using Cre-loxP–mediated gene targeting. We found that Hif-1α enhanced epithelial-to-mesenchymal transition (EMT) in vitro and induced epithelial cell migration through upregulation of lysyl oxidase genes. Genetic ablation of epithelial Hif-1α inhibited the development of tubulointerstitial fibrosis in UUO kidneys, which was associated with decreased interstitial collagen deposition, decreased inflammatory cell infiltration, and a reduction in the number of fibroblast-specific protein–1–expressing (FSP-1–expressing) interstitial cells. Furthermore, we demonstrate that increased renal HIF-1α expression is associated with tubulointerstitial injury in patients with chronic kidney disease. Thus, we provide clinical and genetic evidence that activation of HIF-1 signaling in renal epithelial cells is associated with the development of chronic renal disease and may promote fibrogenesis by increasing expression of extracellular matrix–modifying factors and lysyl oxidase genes and by facilitating EMT.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(14)
| Title and authors |
Publication |
Year |
Angiotensinogen Gene Transcription in Pulmonary Fibrosis
Bruce D. Uhal, My-Trang T. Dang, Xiaopeng Li, Amal Abdul-Hafez
|
International Journal of Peptides
|
2012 |
The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration
X. Yu, Y. Fang, H. Liu, J. Zhu, J. Zou, X. Xu, S. Jiang, X. Ding
|
Nephrology Dialysis Transplantation
|
2012 |
Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease
G. Mayer
|
Nephrology Dialysis Transplantation
|
2011 |
In search of early events in the development of chronic kidney disease: the emerging role for lipocalin-2/NGAL
T. Rauen, R. Weiskirchen, J. Floege
|
Nephrology Dialysis Transplantation
|
2011 |
Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC
S. Frede, P. Freitag, L. Geuting, R. Konietzny, J. Fandrey
|
Blood
|
2011 |
Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane
M. Bignon, C. Pichol-Thievend, J. Hardouin, M. Malbouyres, N. Brechot, L. Nasciutti, A. Barret, J. Teillon, E. Guillon, E. Etienne
|
Blood
|
2011 |
A System Out of Breath: How Hypoxia Possibly Contributes to the Pathogenesis of Systemic Sclerosis
T. W. van Hal, L. van Bon, T. R. D. J. Radstake
|
International Journal of Rheumatology
|
2011 |
MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma
Li-Hsin Chen, Kun-Ling Tsai, Yi-Wei Chen, Cheng-Chia Yu, Kuo-Wei Chang, Shi-Hwa Chiou, Hung-Hai Ku, Pen-Yuan Chu, Ling-Ming Tseng, Pin-I Huang, Wen-Liang Lo
|
Journal of Oncology
|
2010 |
Long-term blockade of vascular endothelial growth factor receptor-2 aggravates the diabetic renal dysfunction associated with inactivation of the Akt/eNOS-NO axis
H. W. Kim, J. H. Lim, M. Y. Kim, S. Chung, S. J. Shin, H. W. Chung, B. S. Choi, Y.-S. Kim, Y. S. Chang, C. W. Park
|
Nephrology Dialysis Transplantation
|
2010 |
Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis
C. Stockmann, Y. Kerdiles, M. Nomaksteinsky, A. Weidemann, N. Takeda, A. Doedens, A. X. Torres-Collado, L. Iruela-Arispe, V. Nizet, R. S. Johnson
|
Proceedings of the National Academy of Sciences
|
2010 |
|